June 19-22, 2017 | San Diego, CA

BIO Exhibition 

Double Helix Sponsor


Schedule at a glance

Registration Rates

Join the Mailing List

Start-Up Stadium

Empowering the Cutting-Edge Companies of Tomorrow, Today

As the world’s largest biotechnology event, the BIO International Convention provides several specialized opportunities geared towards start-up and emerging companies. The Start-Up Stadium was designed to provide start-up companies with the opportunity to engage key members of the investment community, venture philanthropy groups, and BIO attendees. 

This area in the BIO Exhibition provides an exciting and interactive experience where investors provide live feedback and judge 5-7 minute pitches presented by start-up biotech companies.

Maximum Exposure for Start-Ups

The goal of the Start-Up Stadium is to increase engagement with investors, state and regional affiliates, early-stage companies at the beginning of their life-cycle and the burgeoning ecosystem in which they play. This provides resources that boost the biotechnology industry as well as a clear, successful example to stakeholders that early-stage innovation is well represented at the BIO International Convention. 

Through the widespread outreach of this event, we plan to reach entrepreneurial ecosystems in all 50 states and abroad. We plan to reach some of the most overlooked regions for start-ups, which traditionally have limited access to investor engagement, feedback, and representation at the BIO International Convention.

Who Can Participate in the Start-Up Stadium? 

Companies that have....

  • Raised less than $10 million since inception 
  • Fewer than 20 full-time employees 
  • Previous business pitch or competition experience 
  • Must have no experience in BIO One-on-One Partnering 

What Kind of Visibility Will You Receive?

During the BIO International Convention, investor judges attend live presentations and engage in a Q&A providing feedback to finalists. Finalists will participate in one of five sessions in 2-3 days among 40 companies. You present a 5-7 minute pitch, followed by written and oral feedback from investor judges. We encourage participants to request and schedule BIO One-on-One Partnering meetings before you arrive to San Diego (make sure to keep your schedule up to date!)

After the event, BIO collects feedback from start-ups and judges and analyzes the increased engagement between investors and early-stage communities. In late July, BIO follows up with finalists for product and investment status. 

How to Participate & Steps for Submission

Participating in the BIO Start-Up Stadium provides a great opportunity to be featured in an innovative space that drives start-ups and investors to engage and explore opportunities for cutting-edge achievements. Here's how to participate:

  1. Review the criteria and submit an application. Applications will be accepted from March 20 through April 7. Finalists will be notified by April 21.
  2. Once accepted, you will be charged a $699 fee per start-up which includes access to BIO One-on-One Partnering ($3,000+ value). The BIO Programs team will reach out to coordinate your time slot.

Questions? Please contact Nareg Sagherian for more information!



Overview of the Start-Up Stadium Program (PDF)


Thank You to Our 2017 Start-Up Stadium Sponsor!

Mintz Levin Logo

2017 Start Up Stadium Image

BIO 2016 Participating Startups and Investment Firms:

Interesting in participating in San Diego? Email Nareg Sagherian for more information on how to participate at BIO 2017! 

Startups Investors
  • Abcombi Bio
  • Affina Biotechnologies
  • Amayrllis Nucleics
  • Aronora
  • Asana Medical
  • Data4Cure
  • Deepstream VR
  • Dermala
  • Elemeno Health
  • ENB Therapeutics
  • Envisagenics
  • Escend Pharmaceuticals
  • Espero Pharmaceuticals
  • Fibralign Bio
  • IGX Bio
  • Jungla
  • Klyss Biotech
  • Ligandal
  • mFluiDx
  • Mirimmune
  • Naked Biome
  • nGoggle
  • NovoMedix
  • Numedii
  • OmniCyte
  • OneSkin
  • PainQx
  • Phi Therapeutics
  • QuickSilver
  • RxMPT
  • SPR Biosciences
  • SyntheX
  • Velox Bio
  • Veris
  • Virvio Inc.
  • Visolis
  • Xcell Biosciences 
  • X-Therma
  • 5AM Ventures
  • Abingworth
  • BMGF
  • EGB Adviisors
  • Faridan
  • Flagship Ventures
  • J&J Innovation
  • KESA Partners
  • Merieux Developpement
  • NJ Health Foundation
  • NLV
  • Sanderling
  • Sanderling Ventures
  • Sofinnova
  • SR One
  • TPG Biotech
  • Warburg Pincus

History of the BIO Start-Up Stadium

Started in 2015, Start-Up Stadium presented an opportunity for BIO to engage start-ups in the North East region of the United States (NY, NJ, PA) and support companies whose sole purpose is to develop cutting-edge technologies and therapeutic solutions, become commercially viable and have a real and sustained industry impact. We used this platform to assist start-ups in gaining visibility in front of the investment community, attaining live feedback from investor judges, and accessing BIO One-on-One Partnering and educational sessions.  

In 2016, BIO engaged the biotech and pharma start-ups on the West Coast in order to continue building the support structure needed to help early-stage companies become commercially viable and create live-saving treatments.  The presenters at this innovative event became part of the overall resource partner network, reaching a constituency that we were not effectively reaching before.  

For 2017, BIO is seeking to expand access to this unique approach to all domestic and international biotech and pharma start-ups. 



Thank you to our 2017 Sponsors

Double Helix Sponsors

Helix Sponsors

Premier Sponsors